The Kilkenny, Ireland facility will focus on the global manufacturing of sensors for Abbott’s CGM diabetes devices.

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Abbott's Freestyle Libre 2 and 3 are the first CGMs to receive FDA clearance for use during imaging tests like X-rays, CT ...

Abbott announced today that it officially opened a new state-of-the-art manufacturing facility in Kilkenny, Ireland.

More than 800 people will be employed at the plant, which will make more Libre sensors than any of the company’s other facilities.

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, ...

Historically, providers would need to log into separate portals or support different workflows for each CGM manufacturer to review the data from their patients. Additionally, it was cumbersome to ...

Abbott (NYSE: ABT) today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with ...

--(BUSINESS WIRE)--Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce a ...